Axelle Loriot

1.9k total citations
44 papers, 1.3k citations indexed

About

Axelle Loriot is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Axelle Loriot has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Surgery. Recurrent topics in Axelle Loriot's work include Epigenetics and DNA Methylation (19 papers), RNA modifications and cancer (10 papers) and Cancer-related gene regulation (9 papers). Axelle Loriot is often cited by papers focused on Epigenetics and DNA Methylation (19 papers), RNA modifications and cancer (10 papers) and Cancer-related gene regulation (9 papers). Axelle Loriot collaborates with scholars based in Belgium, United States and France. Axelle Loriot's co-authors include Charles De Smet, Thierry Boon, Etienne De Plaen, Tony Kouzarides, Bruno Amati, David Bernard, Pier Giuseppe Pelicci, Rachel Deplus, Carmen Brenner and Arantxa Gutiérrez and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Axelle Loriot

41 papers receiving 1.3k citations

Peers

Axelle Loriot

IMMUN

ONCOL

GENET

Deqiang Sun United States

Kazuo Asanoma Japan

Zhaojuan Yang China

Sébastien Malinge United States

Liubin Yang United States

Hisanobu Oda Japan

Allison Mayle United States

Liat Drucker Israel

Kumiko Goi Japan

Anh T. Nguyen United States

Deqiang Sun United States

Axelle Loriot

1.0k ×0.9

276 ×1.1

373 ×1.7

IMMUN

159 ×0.9

ONCOL

139 ×0.9

GENET

Citations per year, relative to Axelle Loriot Axelle Loriot (= 1×) peers Deqiang Sun

Countries citing papers authored by Axelle Loriot

Since Specialization

Citations

This map shows the geographic impact of Axelle Loriot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axelle Loriot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axelle Loriot more than expected).

Fields of papers citing papers by Axelle Loriot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axelle Loriot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axelle Loriot. The network helps show where Axelle Loriot may publish in the future.

Co-authorship network of co-authors of Axelle Loriot

This figure shows the co-authorship network connecting the top 25 collaborators of Axelle Loriot. A scholar is included among the top collaborators of Axelle Loriot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axelle Loriot. Axelle Loriot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roumain, Martin, Justine Gillard, Axelle Loriot, et al.. (2025). The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia. Gut Microbes. 17(1). 2449586–2449586. 7 indexed citations

Loriot, Axelle, Sabine Cordi, Selda Aydın, et al.. (2024). Spatial transcriptomics profiling of gallbladder adenocarcinoma: a detailed two-case study of progression from precursor lesions to cancer. BMC Cancer. 24(1). 1025–1025. 3 indexed citations

Finisguerra, Veronica, et al.. (2024). Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells. Nature Communications. 15(1). 7789–7789. 5 indexed citations

Tilman, Gaëlle, Axelle Loriot, Joëlle Marchandise, et al.. (2023). Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis. Annals of the Rheumatic Diseases. 82(12). 1538–1546. 7 indexed citations

Haufroid, Vincent, Axelle Loriot, Laurent Gatto, et al.. (2023). Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome. 11(1). 138–138. 35 indexed citations

Loriot, Axelle, Nicolas D. Huyghe, Rose‐Marie Goebbels, et al.. (2023). Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111). Clinical Cancer Research. 29(20). 4076–4087.

Belle, Morgane, Nicolas Dauguet, Younès Achouri, et al.. (2023). Axon guidance genes control hepatic artery development. Development. 150(16).

Liedekerke, Paul Van, et al.. (2022). Quantitative modeling identifies critical cell mechanics driving bile duct lumen formation. PLoS Computational Biology. 18(2). e1009653–e1009653. 10 indexed citations

Loriot, Axelle, et al.. (2022). Identification of Tissue-Specific Gene Clusters Induced by DNA Demethylation in Lung Adenocarcinoma: More Than Germline Genes. Cancers. 14(4). 1007–1007. 3 indexed citations

10.

Berdt, Pauline De, Kévin Vanvarenberg, Bernard Učakar, et al.. (2022). The human dental apical papilla promotes spinal cord repair through a paracrine mechanism. Cellular and Molecular Life Sciences. 79(5). 252–252. 6 indexed citations

11.

Lemoine, Pascale, Nicolas Dauguet, Axelle Loriot, et al.. (2022). BRAFV600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages. Cancers. 14(19). 4687–4687. 2 indexed citations

12.

Assi, Mohamad, Younès Achouri, Axelle Loriot, et al.. (2021). Dynamic Regulation of Expression of KRAS and Its Effectors Determines the Ability to Initiate Tumorigenesis in Pancreatic Acinar Cells. Cancer Research. 81(10). 2679–2689. 12 indexed citations

13.

Corbet, Cyril, Estelle Bastien, Ruben Martherus, et al.. (2021). Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition. Cell Reports. 35(9). 109202–109202. 26 indexed citations

14.

Viceconte, Nikenza, Axelle Loriot, Marion Scheibe, et al.. (2020). PAR-TERRA is the main contributor to telomeric repeat-containing RNA transcripts in normal and cancer mouse cells. RNA. 27(1). 106–121. 17 indexed citations

15.

Gérard, Claude, Stefano Caruso, Gabrielle Couchy, et al.. (2019). Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma. Journal of Hepatology. 71(2). 323–332. 10 indexed citations

16.

Loriot, Axelle, et al.. (2013). Epigenetic Hierarchy within the MAGEA1 Cancer-Germline Gene: Promoter DNA Methylation Dictates Local Histone Modifications. PLoS ONE. 8(3). e58743–e58743. 26 indexed citations

17.

Smet, Charles De & Axelle Loriot. (2010). DNA hypomethylation in cancer: Epigenetic scars of a neoplastic journey. Epigenetics. 5(3). 206–213. 63 indexed citations

18.

Kholmanskikh, Olga, Axelle Loriot, Francis Brasseur, Etienne De Plaen, & Charles De Smet. (2007). Expression of BORIS in melanoma: Lack of association with MAGE‐A1 activation. International Journal of Cancer. 122(4). 777–784. 49 indexed citations

19.

Loriot, Axelle, Etienne De Plaen, Thierry Boon, & Charles De Smet. (2006). Transient Down-regulation of DNMT1 Methyltransferase Leads to Activation and Stable Hypomethylation of MAGE-A1 in Melanoma Cells. Journal of Biological Chemistry. 281(15). 10118–10126. 64 indexed citations

20.

Loriot, Axelle, Thierry Boon, & Charles De Smet. (2003). Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia. International Journal of Cancer. 105(3). 371–376. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact